|1.||Antonopoulou, Smaragdi: 15 articles (10/2015 - 04/2002)|
|2.||Demopoulos, Constantinos A: 13 articles (09/2014 - 04/2002)|
|3.||Fragopoulou, Elizabeth: 12 articles (10/2015 - 04/2002)|
|4.||Ishii, Satoshi: 12 articles (02/2015 - 03/2002)|
|5.||Shimizu, Takao: 11 articles (02/2015 - 01/2002)|
|6.||Finkelman, Fred D: 9 articles (03/2015 - 04/2002)|
|7.||Travers, Jeffrey B: 9 articles (12/2014 - 05/2003)|
|8.||Im, Suhn-Young: 9 articles (09/2014 - 05/2006)|
|9.||Bazan, Nicolas G: 9 articles (03/2012 - 02/2003)|
|10.||Denizot, Yves: 9 articles (06/2010 - 04/2003)|
|1.||Asthma (Bronchial Asthma)
04/01/1998 - "We conclude that SR 27417A is effective in inhibiting systemic, cellular and pulmonary effects after platelet-activating factor challenge in patients with mild bronchial asthma."
10/01/1992 - "Platelet-activating factor antagonists may partially be effective in asthma through inhibitory effects on neutrophil chemotaxis."
01/01/2008 - "Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy."
09/01/1999 - "The pathogenic role of platelet-activating factor (PAF) in asthma has been questioned due to the limited or negative efficacy of PAF antagonists; however, in acute asthma (AA), where the endogenous release of PAF may be enhanced, the effects of PAF antagonist receptors have not been investigated. "
03/15/2000 - "Numerous in vitro and in vivo studies in both animal models and human asthmatics have implicated platelet-activating factor (PAF) as an important inflammatory mediator in asthma. "
|2.||Anaphylaxis (Anaphylactic Shock)
08/01/1998 - "In order to find out anti-platelet activating factor (PAF) from natural resources, Korean medicinal plants used for the treatments of peripheral circulation disorders were tested for their possible protective effects on PAF-induced anaphylactic shock. "
01/01/2011 - "Mechanistic studies showed that the food allergic systemic anaphylaxis was dependent on platelets, FcRγ and mast cells, and partially dependent on platelet activating factor and monocytes/macrophages, depending on mouse strain. "
06/01/2015 - "Platelet-activating factor (PAF) is a potent phospholipid-derived mediator the central role of which has been well established in experimental models of both immune-mediated and non-immune mediated anaphylaxis. "
06/01/2015 - "Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis."
01/01/2014 - "Platelet-activating factor (PAF) is a highly potent phospholipid mediator responsible for the life-threatening manifestations of anaphylaxis. "
04/01/2000 - "The purpose of the present study was to determine if platelet-activating factor is an important mediator that produces vasospasm during reperfusion after ischemia in skeletal muscle. "
06/01/1997 - "Platelet-activating factor expression within musculocutaneous flaps subjected to ischemia and reperfusion was non directly demonstrated in this study. "
01/01/1996 - "The purpose of this study was to evaluate the renoprotective effect of a specific platelet-activating factor antagonist (WEB-2086) in an experimental model of normothermic renal ischemia. "
03/21/1994 - "This study investigated the distribution of platelet activating factor (PAF) binding sites in the brain and their involvement in global ischemia in a model of bilateral common carotid occlusion in the gerbil. "
02/01/1993 - "This study investigated the role of platelet-activating factor in the recruitment of polymorphonuclear neutrophils (PMN) in a rabbit model of cardiac ischemia and reperfusion. "
07/01/2001 - "The effect of platelet-activating factor (PAF) in the pathogenesis of acute pancreatitis has been proved in various studies. "
08/01/2000 - "To study the role of platelet activating factor (PAF) in the pathogenesis of intestinal mucosal injury and endotoxin/bacterial translocation in acute severe pancreatitis (ASP) in pigs. "
06/01/1998 - "The initial studies on the therapeutic significance of lexipanphate-antagonist of platelet activating factor (PAF) in acute pancreatitis is promising. "
07/01/1993 - "This study demonstrates the formation of platelet-activating factor (PAF) in rats with acute experimental pancreatitis (AEP). "
10/01/1992 - "This study investigates the role of platelet-activating factor (PAF) in experimental pancreatitis. "
01/01/1997 - "This study aimed at evaluating the role of platelet-activating factor (PAF) on cardiovascular dysfunction in postischemic shock in pigs. "
01/01/1995 - "This study aimed at evaluating the role of platelet-activating factor (PAF) antagonism in haemorrhagic shock in juvenile pigs. "
08/01/1994 - "This study was designed to investigate the role of PAF blockade during experimental Gram-positive shock by pretreatment with platelet activating factor-antagonist (PAF-A). "
12/01/1992 - "[Experimental study on platelet activating factor and systemic circulatory failure caused by ischemic liver]."
10/01/1990 - "[An experimental study on shock after temporary hepatic inflow occlusion and platelet activating factor (PAF)]."
|1.||Histamine (Histamine Dihydrochloride)
|2.||WEB 2086 (apafant)
|4.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|5.||Platelet Activating Factor
|7.||Arachidonic Acid (Vitamin F)
|5.||Homologous Transplantation (Allograft)